BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32307261)

  • 1. Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences.
    Raballo A; Poletti M; Preti A; McGorry P
    Schizophr Res; 2022 May; 243():254-261. PubMed ID: 32307261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of gender differences in transition prevalence among individuals at clinical high risk of psychosis.
    He XY; Wang SB; Hou CL; Guo LL; Huang ZH; Zhao QN; Li D
    Asian J Psychiatr; 2023 Aug; 86():103639. PubMed ID: 37307702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.
    Solmi M; Soardo L; Kaur S; Azis M; Cabras A; Censori M; Fausti L; Besana F; Salazar de Pablo G; Fusar-Poli P
    Mol Psychiatry; 2023 Jun; 28(6):2291-2300. PubMed ID: 37296309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.
    Salazar de Pablo G; Catalan A; Vaquerizo Serrano J; Pedruzo B; Alameda L; Sandroni V; Armendariz A; Rodriguez V; Arango C; Moreno C; Downs J; Abbott C; Shin JI; Solmi M; Fusar-Poli P; Correll CU
    Br J Psychiatry; 2023 Jul; 223(1):282-294. PubMed ID: 37194556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.
    Oliver D; Arribas M; Radua J; Salazar de Pablo G; De Micheli A; Spada G; Mensi MM; Kotlicka-Antczak M; Borgatti R; Solmi M; Shin JI; Woods SW; Addington J; McGuire P; Fusar-Poli P
    Mol Psychiatry; 2022 Sep; 27(9):3670-3678. PubMed ID: 35665763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.
    Salazar de Pablo G; Radua J; Pereira J; Bonoldi I; Arienti V; Besana F; Soardo L; Cabras A; Fortea L; Catalan A; Vaquerizo-Serrano J; Coronelli F; Kaur S; Da Silva J; Shin JI; Solmi M; Brondino N; Politi P; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2021 Sep; 78(9):970-978. PubMed ID: 34259821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse outcome analysis in people at clinical high risk for psychosis: results from a 2-year Italian follow-up study.
    Pelizza L; Leuci E; Quattrone E; Azzali S; Pupo S; Paulillo G; Menchetti M; Pellegrini P
    Soc Psychiatry Psychiatr Epidemiol; 2024 Jul; 59(7):1177-1191. PubMed ID: 38091031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline benzodiazepine exposure is associated with greater risk of transition in clinical high-risk for psychosis (CHR-P): a meta-analysis.
    Raballo A; Poletti M; Preti A
    Psychol Med; 2023 Aug; ():1-7. PubMed ID: 37609894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The temporal dynamics of transition to psychosis in individuals at clinical high-risk (CHR-P) shows negative prognostic effects of baseline antipsychotic exposure: a meta-analysis.
    Raballo A; Poletti M; Preti A
    Transl Psychiatry; 2023 Apr; 13(1):112. PubMed ID: 37019886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analyzing the prevalence and prognostic effect of antipsychotic exposure in clinical high-risk (CHR): when things are not what they seem.
    Raballo A; Poletti M; Preti A
    Psychol Med; 2020 Dec; 50(16):2673-2681. PubMed ID: 33198845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
    Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
    JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project.
    Poletti M; Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Gebhardt E; Pupo S; Andrea R
    Eur Child Adolesc Psychiatry; 2019 Jul; 28(7):957-971. PubMed ID: 30506419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do antidepressants prevent transition to psychosis in individuals at clinical high-risk (CHR-P)? Systematic review and meta-analysis.
    Raballo A; Poletti M; Preti A
    Psychol Med; 2023 Jul; 53(10):4550-4560. PubMed ID: 35655405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
    Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
    JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
    Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
    Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.